Is There Any Potential Left In Mobileiron Inc (MOBL), Titan International Inc (TWI) and Sophiris Bio Inc (SPHS)?

Posted by admin May 5, 2015 0 Comment 542 views

New York, NY – GDP INSIDER  –  05/05/2014.

This article discusses three companies: Mobileiron Inc (NASDAQ:MOBL), Titan International Inc (NYSE:TWI) and Sophiris Bio Inc (NASDAQ:SPHS)

Mobileiron Inc (NASDAQ:MOBL) declined yesterday with the stock losing $0.52 to finish the day at a closing price of $6.13, a 7.82% decline in value from its previous closing price of $6.65 on slightly higher than average trading volume of 0.758 million, compared to its three month average trading volume of 0.537 million. Over the past one month and over the past three months, the stock has lost 31.66% and 30.81%, respectively. The RSI and MFI are both very low at 28.33 and 28.91.  However, this is not a signal of a reversal and fundamentals are very uncertain.

Click Here To See How Low Mobileiron Inc Can Still Go With Our Free MOBL Investment Analysis.

Titan International Inc (NYSE:TWI) continued to climb yesterday as the stock gained $0.59 to move to a new closing price of $11.96, a 5.19% increase in value from the previous closing price of $11.37. The new mark places the stock $36.37 above its 52 week low of $8.77. Illinois-based manufacturer of wheels and tires recorded a trading volume of 1.121 million on Monday, a figure which is higher than its three month average of 0.608 million. The RSI did surge to 81 following the increase and the MFI is 84. The stock could go through a minor correction with these technical in or close to the level of concern.  However, our reports show that the stock still has upside.

Do Titan International Inc’s Technical Indicators Support Its Current Value? Receive A Free TWI Analysis Here.

Sophiris Bio Inc (NASDAQ:SPHS) reversed its recent downward trend yesterday with the stock gaining 7.77% or $0.05 to close at $0.75 on light trading of 0.204 million shares compared to its three month average trading volume of 0.590 million. The clinical stage biopharmaceutical company focusing on products to treat urological diseases has been trading between $0.44 and $1.20 for the last three months, without showing any signs of breaking out. However, the company is well financed with a current ratio of 4.60 and any major breakthrough in its research could push the stock up fast making it a potential medium to long term hold.

What Does The Future Hold For Sophiris Bio Inc? Click Here For Free SPHS Analysis.

About Ultimate Stock Alerts covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit

Disclosure: is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment